eEF1A1 antibody (C-Term)
Quick Overview for eEF1A1 antibody (C-Term) (ABIN629602)
Target
See all eEF1A1 (EEF1A1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- EEF1 A1 antibody was raised against the C terminal of EEF1 1
-
Purification
- Purified
-
Immunogen
- EEF1 A1 antibody was raised using the C terminal of EEF1 1 corresponding to a region with amino acids IVDMVPGKPMCVESFSDYPPLGRFAVRDMRQTVAVGVIKAVDKKAAGAGK
-
-
-
-
Application Notes
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
EEF1A1 Blocking Peptide, (ABIN939582), is also available for use as a blocking control in assays to test for specificity of this EEF1A1 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EEF0 1 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- eEF1A1 (EEF1A1) (Eukaryotic Translation Elongation Factor 1 alpha 1 (EEF1A1))
-
Alternative Name
- EEF1A1
-
Background
- EEF1A1 is an isoform of the alpha subunit of the elongation factor-1 complex, which is responsible for the enzymatic delivery of aminoacyl tRNAs to the ribosome. This isoform (alpha 1) is expressed in brain, placenta, lung, liver, kidney, and pancreas, and the other isoform (alpha 2) is expressed in brain, heart and skeletal muscle. This isoform is identified as an autoantigen in 66% of patients with Felty syndrome.
-
Molecular Weight
- 50 kDa (MW of target protein)
Target
-